Immunization against viral infections associated with human cancer: the promise of modern biotechnology.
D001709:Biotechnology; D003362:Cost-Benefit Analysis; D005818:Genetic Engineering; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D014611:Vaccination; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D014777:Virus Diseases / Q000517:prevention & control*
D014613:Vaccines, Attenuated; D014765:Viral Vaccines